Merck stock drops 1.25% as company posts strong Phase 3 HIV data with Gilead Sciences

Traders Union
All News
Companies
Merck slides 1.25% today to $119.47

Highlights

MRK maintains a strong bullish structure across all timeframes, trading well above key moving averages.
Momentum remains mostly positive with technical indicators supporting price stability or moderate upside, while overbought conditions show limited downside risk.
The expected trading range for the coming week is $118.92 to $119.67, with bullish potential if resistance is breached.

Bullish structure maintained as price holds above support levels

MRK is trading at $119.47, which is well above the MA-20 ($115.83), MA-50 ($116.18), and MA-200 ($103.93). This alignment confirms strong underlying bullish structure across short-, medium-, and long-term timeframes. The current Ichimoku Kijun level on D1 is $116.04, which is below the current price and acts as immediate support. Near-term support lies at the Ichimoku Kijun ($116.04), while key support is the MA-50 ($116.18). Near-term resistance is at the MA-5 ($117.35), and key resistance is at the MA-10 ($118.77).

Mixed momentum signals amid consolidation and short-term overbought risks

Momentum indicators remain mostly positive. MACD on D1 is in buy mode, though ADX on D1 signals a weak trend at 15.01. RSI on D1 is at 59.92, indicating mild bullish momentum without overbought conditions, while CCI is flagged as overbought. BBP suggests buyers are currently dominant, but Stoch RSI and the oscillators give mixed messages, with Stoch RSI neutral and some short-term overbought readings. MRK has fallen $1.51 (1.25%) over the last week, trading down from the previous weekly close at $120.98. The price is currently in the middle of its weekly range and weekly volatility stands at 7.82%. The tone for the week shows consolidation after a steady decline from the high. In today's session, the stock posted a notable 1.25% drop.

High probability of stability as long-term buy signals persist

Looking ahead, the expected price range for the coming week is $118.92 to $119.67, keeping MRK near the middle of its annual band between the 52-week low ($76.66) and high ($125.14). Based on strong buy signals across RSI (W1), ADX (W1), MACD (W1), and longer-term MAs, there is a very high probability (more than 80%) of price stability or moderate upside, with a very low probability of a sustained decline. The baseline scenario favors sideways movement within the defined band. The bullish scenario would be activated if MRK breaks above near-term resistance, which could signal a retest of yearly highs. Conversely, a clear drop below immediate support could trigger a bearish move toward the lower part of the weekly range, but this is less likely given current momentum.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that Merck shares displayed strong bullish momentum with limited downside risk, as technical indicators supported a continued upward trend. In light of the latest developments, traders should monitor for a possible breakout or renewed consolidation, with the prevailing scenario favoring a cautious but optimistic stance on Merck’s potential for further gains.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.